Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection

J Infect Dis. 2022 Sep 21;226(6):1084-1097. doi: 10.1093/infdis/jiab547.

Abstract

Background: Interplay between vaginal microbiome and human papillomavirus (HPV) remains unclear, partly due to heterogeneity of microbiota.

Methods: We used data from 546 women enrolled in a cross-sectional study in 5 Brazil. We genotyped vaginal samples for HPV and sequenced V3-V4 region of 16S rRNA gene for vaginal microbiome analysis. We used stepwise logistic regression to construct 2 linear scores to predict high-risk HPV (hrHPV) positivity: one based exclusively on presence of individual bacterial taxa (microbiome-based [MB] score) and the other exclusively on participants' sociodemographic, behavioral, and clinical (SBC) characteristics. MB score combined coefficients of 30 (of 116) species. SBC score retained 6 of 25 candidate variables. We constructed receiver operating characteristic curves for scores as hrHPV correlates and compared areas under the curve (AUC) and 95% confidence intervals (CI).

Results: Overall, prevalence of hrHPV was 15.8%, and 26.2% had a Lactobacillus-depleted microbiome. AUCs were 0.8022 (95% CI, .7517-.8527) for MB score and 0.7027 (95% CI, .6419-.7636) for SBC score (P = .0163).

Conclusions: The proposed MB score is strongly correlated with hrHPV positivity-exceeding the predictive value of behavioral variables-suggesting its potential as an indicator of infection and possible value for clinical risk stratification.

Keywords: 16S RNA sequencing; HPV infection; high-risk HPV; vaginal microbiome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphapapillomavirus* / genetics
  • Cross-Sectional Studies
  • Female
  • Humans
  • Microbiota* / genetics
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / epidemiology
  • RNA, Ribosomal, 16S / genetics
  • Uterine Cervical Neoplasms*
  • Vagina / microbiology

Substances

  • RNA, Ribosomal, 16S